Miguel J. Lanz, MD, FAAAAI, FACAAI

Physician

Lanz Allergy, Asthma & Immunology

AAADRS Clinical Research Center

Doctors Hospital

Nicklaus Children’s Hospital

Coral Gables, FL

Linda Rogers, MD

Professor of Medicine

Icahn School of Medicine at Mt Sinai

Department of Medicine

Division of Pulmonary, Critical Care, and Sleep Medicine

Clinical Director, Adult Asthma Program

Medical Director, Medicine Clinical Trials Office New York, NY

Eileen Wang, MD, MPH

Associate Professor

Division of Allergy and Clinical Immunology

Department of Medicine

National Jewish Health

University of Colorado School of Medicine

Denver, Colorado

Michael E. Wechsler, MD, MMSc

Director, The Cohen Family Asthma Institute

Professor of Medicine

Division of Pulmonary, Critical Care, & Sleep Medicine

National Jewish Health

Denver, CO

ACCREDITATION STATEMENT:

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION:

National Jewish Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the

 evaluation component, enables the participant to earn up to 1.0 MOC points in

the American Board of Internal Medicine’s (ABIM) Maintenance of

Certification (MOC) program. It is the CME activity provider’s responsibility

to submit participant completion information to ACCME for the purpose of granting ABIM

MOC credit.

To earn ABIM MOC points, participants must view the program, respond to the polling questions, and complete the post-test and evaluation.

DISCLOSURES OF CONFLICTS OF INTEREST:

Disclosure of Financial Relationships

In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, reviewers, and others in a position to control the content of this activity disclose to learners the presence or absence of any relevant financial relationships with an ACCME-defined ineligible company within the preceding 24 months of the activity. The ACCME defines an “ineligible company” as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Our goal is to ensure that there is no compromise in the ethical relationship that exists between those in a position to control the content of the activity and those participating in the activity and their respective professional duties. All accredited education activities offered by National Jewish Health are reviewed to ensure a balanced and evidence-based presentation.

Faculty Disclosures:

Ayodeji Adegunsoye, MD, MSc, PhD, FCCP discloses the following relevant financial relationships:

Advisory Board: Inogen

Consultant: Avalyn, Boehringer Ingelheim

Speaker: Boehringer Ingelheim

Barbara Goldstein, MD does not have any relevant financial relationships to disclose.

Joshua J. Solomon, MD does not have any relevant financial relationships to disclose.

Planner/Reviewer Disclosures:

Laniecia Demmer does not have any relevant financial relationships to disclose.

Meghan Brenner, MA -does not have any relevant financial relationships to disclose.

Andrea Harshman, MHA, CHCP, CMP-HC does not have any relevant financial relationships to disclose.

Liudmila Kastsianok, MD, RhMSUS, FACR discloses the following relevant financial relationships:

              Speaker: Boehringer Ingelheim

Zulma Yunt, MD discloses the following relevant financial relationships:

                  Consultant: Johnson and Johnson

                  Speaker: Boehringer Ingelheim